Renee Hart

Company: LumaCyte

Job title: President & Chief Business Officer

Seminars:

Panel Discussion: Navigating Resistance to Innovation in Pharma & Strategies to Secure Stakeholder Buy-In for New Technologies 4:15 pm

Sharing of knowledge on challenges encountered with key decision makers in implementing PAT Crowd-source solutions to align stakeholders and gain buy-in for prioritising PAT in both development and manufacturingRead more

day: Conference Day One

Panel Discussion: Exploring the Major Advancements & Challenges of PAT in Drug Development & Manufacturing to Enhance Collaboration & Innovation 9:00 am

Highlighting emerging trends and technologies for real-time process control Identifying the industry-wide obstacles professionals working with PAT are facing in 2025 Proposing approaches to tackle technical, data management and business challengesRead more

day: Conference Day One

Quantitative Cellular PAT Analytics Driving Improvements in Advanced Therapy Process & Production Outcomes 9:45 am

Label-free analysis of intrinsic biochemical and biophysical properties of cells provides real-time insights into cellular changes occurring throughout a manufacturing process Learn how Laser Force Cytology™, a label-free, quantitative precision PAT enables real-time monitoring of CQAs and CPPs delivers insights into complex manufacturing processes through its optical force univariate and multivariate machine learning predictive capabilitiesRead more

day: Conference Day One